SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 201.28-2.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (30125)1/11/2000 3:21:00 PM
From: Alper H.YUKSEL  Read Replies (1) of 32384
 
A rather anemic coverage of LGND's presentation by CBS Marketwatch :

Ligand in position

Ligand Pharmaceuticals Chief Executive Officer David Robinson said his company is positioned to be one of the major biotech companies of the new millenium. He said a recent series of "value creating activities," including three new oncology approvals, will drive growth at Ligand (LGND: news, msgs). The company hopes the drugs Ontak and Targretin will help it reach its goal of profitability this year, Robinson said. Other objectives include pursuing new uses for its existing drugs and strengthening the company's balance sheet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext